The potential role of cardiac resynchronization therapy in acute heart failure syndromes

Norman C. Wang*, Sanjoy Bhattacharya, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Cardiac resynchronization therapy (CRT) has been demonstrated to improve mortality and morbidity in patients with chronic, stable heart failure who have reduced left ventricular ejection fraction and prolonged QRS duration. Patients with acute heart failure syndromes (AHFS) have been excluded from major CRT trials. The potential benefits and risks of implementation of these devices in the AHFS setting are largely unknown. In this review, we discuss the role that early implementation of CRT may have in improving postdischarge outcomes. In addition, we also discuss the potential adverse consequences of inserting these devices in patients who are in the tenuous clinical state of AHFS.

Original languageEnglish (US)
Pages (from-to)481-490
Number of pages10
JournalHeart Failure Reviews
Volume16
Issue number5
DOIs
StatePublished - Sep 1 2011

Keywords

  • Cardiac resynchronization therapy
  • Heart failure
  • Hospitalization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The potential role of cardiac resynchronization therapy in acute heart failure syndromes'. Together they form a unique fingerprint.

Cite this